Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FQAJZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,234
Award facts
- Contract value 100% obligated
- $22,233.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $22,233.54 by the Defense Logistics Agency on September 24, 2025, for the supply of Photrexa Cross-Linking Kit 6ml. The award is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and no set-aside designation was utilized in the procurement. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to serve military health systems. The Photrexa Cross-Linking Kit delivery represents the company's ongoing role in supplying specialized pharmaceutical products to Department of Defense healthcare sites. The contractor's established presence in federal procurement markets, combined with its woman-owned small business status and longstanding registration in the System for Award Management since 2001, positions it as a key pharmaceutical distributor for government healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQAJZ?
SPE2DB25FQAJZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FQAJZ worth?
The government has obligated $22,234 on SPE2DB25FQAJZ.
Is contract SPE2DB25FQAJZ an order under another contract?
Yes. SPE2DB25FQAJZ is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJZ competed?
The extent of competition for SPE2DB25FQAJZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award